metricas
covid
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Caplacizumab in acquired thrombotic thrombocytopenic thrombocytopenic purpura: d...
Journal Information

Statistics

Follow this link to access the full text of the article

Scientific letter
Caplacizumab in acquired thrombotic thrombocytopenic thrombocytopenic purpura: dose adjustment based on von Willebrand factor level
Caplacizumab en la púrpura trombocitopénica trombótica adquirida: ajuste de la dosis basado en el factor de von Willebrand
Marta Albanell-Fernándeza,
Corresponding author
malbanell@clinic.cat

Corresponding author.
, Inés Monge-Escartína, Joan Cidb
a Servicio de Farmacia, Àrea del Medicament, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain
b Aféresis y Unidad de Terapia Celular, Departamento de Hemoterapia y Hemostasia, ICMHO, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain
Read
Not available
Times
was read the article
Total PDF
Total HTML
Share statistics
Article information
ISSN: 23870206
Original language: English
The statistics are updated each day

Follow this link to access the full text of the article

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos